Treating to target patients with primary hyperlipidemia: Comparison of the effects of atorvastatin and rosuvastatin (the atoros study)

被引：0
|
作者：
Milionis, H.
Rizos, E.
Kostapanos, M.
Filippatos, T.
Goudevenos, J.
Mikhailidis, D.
Elisaf, M.
机构：
[1] Univ Ioannina, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Royal Free Hosp, Dept Clin Biochem, London NW3 2QG, England
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)82339-1
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
ThP16381
引用
收藏
页码：577 / 577
页数：1
相关论文
共 50 条
  • [41] Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
    Christian Berne
    Annica Siewert-Delle
    Cardiovascular Diabetology, 4
  • [42] Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia
    Olsson, AG
    Istad, H
    Luurila, O
    Ose, L
    Stender, S
    Tuomilehto, J
    Wiklund, O
    Southworth, H
    Pears, J
    Wilpshaar, JW
    AMERICAN HEART JOURNAL, 2002, 144 (06) : 1044 - 1051
  • [43] Effects of pravastatin, atorvastatin, and rosuvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia
    Mori H.
    Okada Y.
    Tanaka Y.
    Diabetology International, 2013, 4 (2) : 117 - 125
  • [44] Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
    Firouzi, Ata
    Moussavi, Ali Kazem
    Mohebbi, Ahmad
    Aleinzadeh-Ansari, Mohammad Javad
    Kiani, Reza
    Sanati, Hamid Reza
    Mohebbi, Bahram
    Shakerian, Farshad
    Zahedmehr, Ali
    Ansari-Ramandi, Mohammad Mostafa
    Heris, Saeed Oni
    Ghaleshi, Bahar
    Ghorbani, Fatemeh
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2018, 10 (03) : 149 - 152
  • [45] Effects of Atorvastatin and Rosuvastatin on Renal Function in Patients With Type 2 Diabetes Mellitus
    Lai, Chao-Lun
    Chou, Hsu-Wen
    Chan, K. Arnold
    Lai, Mei-Shu
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (05): : 619 - 624
  • [46] Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
    Golshani, Samad
    Tavasoli, Parastoo
    Farsavian, Ali Asghar
    Farsavian, Hossein
    Charati, Jamshid Yazdani
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (05) : 1957 - 1962
  • [47] Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers
    van Himbergen, Thomas M.
    Matthan, Nirupa R.
    Resteghini, Nancy A.
    Otokozawa, Seiko
    Ai, Masumi
    Stein, Evan A.
    Jones, Peter H.
    Schaefer, Ernst J.
    JOURNAL OF LIPID RESEARCH, 2009, 50 (04) : 730 - 739
  • [48] Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia -: Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
    Clearfield, Michael B.
    Amerena, John
    Bassand, Jean-Pierre
    Hernandez Garcia, Hugo R.
    Miller, Sam S.
    Sosef, Froukje F. M.
    Palmer, Michael K.
    Bryzinski, Brian S.
    TRIALS, 2006, 7 (1)
  • [49] Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
    Michael B Clearfield
    John Amerena
    Jean-Pierre Bassand
    Hugo R Hernández García
    Sam S Miller
    Froukje FM Sosef
    Michael K Palmer
    Brian S Bryzinski
    Trials, 7
  • [50] Comparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndrome
    Khurana, Sushant
    Gupta, Surabhi
    Bhalla, HiraLal
    Nandwani, Shefali
    Gupta, Varad
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2015, 6 (03) : 130 - 135
12345